Reversible acetylation regulates vascular endothelial growth factor receptor-2 activity
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The tyrosine kinase receptor vascular endothelial growth factor receptor 2 (VEGFR2) is a key regulator of angiogenesis. Here we show that VEGFR2 is acetylated in endothelial cells both at four lysine residues forming a dense cluster in the kinase insert domain and at a single lysine located in the receptor activation loop. These modifications are under dynamic control of the acetyltransferase p300 and two deacetylases HDAC5 and HDAC6. We demonstrate that VEGFR2 acetylation essentially regulates receptor phosphorylation. In particular, VEGFR2 acetylation significantly alters the kinetics of receptor phosphorylation after ligand binding, allowing receptor phosphorylation and intracellular signaling upon prolonged stimulation with VEGF. Molecular dynamics simulations indicate that acetylation of the lysine in the activation loop contributes to the transition to an open active state, in which tyrosine phosphorylation is favored by better exposure of the kinase target residues. These findings indicate that post-translational modification by acetylation is a critical mechanism that directly affects VEGFR2 function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of cellular metabolism by protein lysine acetylation
Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910 · cited 1×
“Among the most prominent PTMs, lysine acetylation has emerged in the last decade as a crucial modification that regulates both nuclear and cytoplasmic processes by targeting a variety of non-histone proteins (Zhao et al., 2010).”
BackgroundLysine Acetylation: Codified Crosstalk with Other Posttranslational Modifications
Yang, X.-J., & Seto, E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.002 · Cited by 1,006 · cited 7×
“116 | Journal of Molecular Cell Biology (2014), 6, 116–127 doi:10.1093/jmcb/mju010 Published online March 11, 2014 at U niversity of Prince E dw ard Island on M arch 2, 2015 http://jm cb.oxfordjournals.org/ D ow nloaded from various PTMs, a sort of ‘protein modification code’ responsible for the final regulation of pr…”
BackgroundInfluentialDeroanne, C. F., Bonjean, K., Servotte, S., Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J.-M., Nusgens, B. V., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205108 · Cited by 400 · cited 4×
“The apparent contradiction between the use of KDACi to inhibit tumor angiogenesis and our novel findings linking VEGFR2 hyperacetylation with increased receptor activation might be partially explained by the fact that prolonged deacetylases inhibition has a major impact on gene expression, rather than on the fine tuni…”
BackgroundInfluential
Cited by
Vascular heterogeneity and specialization in development and disease
Potente, M., & Mäkinen, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.36 · Cited by 653
The Link Between Angiogenesis and Endothelial Metabolism
Potente, M., & Carmeliet, P. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105134 · Cited by 354
Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease
Li, P., Ge, J., & Li, H. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0235-9 · Cited by 269
Targeting the acetylation signaling pathway in cancer therapy
Dang, F., & Wei, W. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.001 · Cited by 109
Metadata
- Authors
- Zecchin, A., Pattarini, L., Gutierrez, M. I., Mano, M., Mai, A., Valente, S., Myers, M. P., Pantano, S., & Giacca, M.
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-11
- Volume
- 6
- Issue
- 2
- Pages
- 116-127
- ISSN
- 1674-2788 (ISSN-L)
- 1759-4685
- OpenAlex
- W2111353955
- Cited by
- 37
- References
- 3
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reversible acetylation regulates vascular endothelial growth factor receptor-2 activity. https://app.cochat.ai/papers/10.1093/jmcb/mju010
- The paper
- Zecchin, A., Pattarini, L., Gutierrez, M. I., Mano, M., Mai, A., Valente, S., Myers, M. P., Pantano, S., & Giacca, M. (2014). Reversible acetylation regulates vascular endothelial growth factor receptor-2 activity. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mju010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.